PVLA

PALVELLA THERAPEUTICS, INC.

Healthcare · Biotechnology

$259.91 sample

-3.23 (-1.23%) 1D

Market cap

$1.25T

Price as of

2026-10-03

Latest filing

8-K

Alerts

8

Price$259.91 +4.99% 3M daily closessample

268.05242.89

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 25INSInsider sell: 10% owner
Sep 21INSInsider sell: Chief Financial Officer
Sep 16INSInsider buy: Chief Executive Officer
Sep 10INSInsider sell: Chief Executive Officer
Sep 07INSInsider sell: EVP, Operations
Aug 31INSInsider sell: Chief Executive Officer
Aug 20INSInsider sell: General Counsel
Aug 13INSInsider buy: General Counsel

Sign up to see the real PVLA record →

Company facts

SEC EDGAR registration

Name: PALVELLA THERAPEUTICS, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +52sample, -100 to +100
Reporting currency: USD

Who is positioning in PVLA

sample

Insiders: 24 insider transactions over 90 days, net selling, $172.1M
Congress: 2 members traded over 90 days
Institutions · 13F: 5 funds hold $17.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$46.3B +16.4% y/y

Q4 2024Q3 2026

Inventory$25.8B +5.5% y/y

Q4 2024Q3 2026

Accounts receivable$19.8B +9.9% y/y

Q4 2024Q3 2026

Total debt$54.2B +14.4% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $664.5B +3.8% 3M
Sample peer B: $1.06T -4.7% 3M
Sample peer C: $538.4B -8.4% 3M
Sample peer D: $743.6B -6.3% 3M
Sample peer E: $498.4B +13.8% 3M